Tracking patients who get a new pulmonary valve implant
Part of Genetic & congenital, Heart & circulation clinical trials.
This study observes patients who receive a new type of replacement heart valve (called the PULSTA valve) placed inside their own pulmonary valve. It helps doctors learn how well the valve works and how safe it is in everyday medical care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate or severe leaking or narrowing of your pulmonary valve (the valve that controls blood flow from your heart to your lungs).
- Your doctor plans to place a new valve inside your existing pulmonary valve using a thin tube inserted through a blood vessel (this is called transcatheter pulmonary valve implantation).
- You are willing to join the study and sign a consent form.
- You do not have any medical condition that would make the valve placement unsafe (as listed in the device's instructions).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new less-invasive heart valve (VenusP-Valve) for people whose own pulmonary valve is leaking severely. If you qualify, you could get the new valve without open-heart surgery.
This study tests an early, first-use version of a new pulmonary valve device for children whose own valve is not working well. It may help improve blood flow from the heart to the lungs and aims to learn how safe and effective the valve is over time.
This observational study follows people who need a pulmonary valve treatment, to see how the Venus P-Valve works in real-world care. It may help doctors understand which patients benefit and how outcomes change over time.
This study tests a new type of replacement valve for children who need a new pulmonary valve (the valve between the heart and lungs). Researchers want to see if the valve works safely and well in real-world use.
This trial is studying how well a new type of heart valve works in real-life patients with aortic valve disease. It will help doctors understand if this valve is safe and effective for people who need a procedure called TAVR (transcatheter aortic valve replacement).
This study looks at how replacing a narrowed heart valve affects fluid in the lungs. It may help doctors better understand recovery after this procedure.
Hear when a new Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.